CLVSQ — Clovis Oncology Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $2.17m
- $604.23m
- $148.76m
Clovis Oncology hits over 6-month high as investors reject reverse stock split
Brief: Clovis Oncology Says Had A Type A Meeting With The FDA
Brief: Clovis Oncology Highlights Phase 1 Data From Ongoing Clinical Studies Of Targeted Radiotherapy Candidate Fap-2286
U.S. STOCKS ON THE MOVE-Microsoft, Ciena, nCino,
U.S. STOCKS ON THE MOVE-Immunic, UiPath, Blue Apron
U.S. STOCKS ON THE MOVE-C3.ai, Chewy, oil companies
Bluebird, Chimerix, Clovis have under 6 months of cash left - Truist
Clovis Oncology Inc reports results for the quarter ended in March - Earnings Summary
Clovis Oncology falls after delaying data for cancer drug
Brief: Clovis Oncology Announces First Quarter 2022 Operating Results And Provides Update On Clinical Development Programs
Clovis Oncology Inc expected to post a loss of 43 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Baidu, Clarus, cruise operators
U.S. STOCKS ON THE MOVE-Datadog Inc, Expensify Inc, Walgreens
U.S. STOCKS ON THE MOVE-Walgreens, Baidu, Masimo Corp
U.S. STOCKS ON THE MOVE-UiPath Inc, Tesla Inc, Oil firms
Clovis Oncology jumps on drug data from ovarian cancer study
Brief: Clovis Oncology And Evergreen Theragnostics Initiate Agreement For Actinium-225-Labeled FAP-2286
Clovis Oncology Inc reports results for the quarter ended in December - Earnings Summary
Brief: Clovis Oncology Reports Quarterly Loss Per Share Of $0.50